STOCK TITAN

Bausch Health Announces Participation At The Jefferies Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Bausch Health Companies Inc. (NYSE/TSX: BHC) announced participation in the Jefferies Healthcare Conference on June 2, 2021, at 11:00 a.m. ET. CEO Joseph C. Papa, senior VP Sam Eldessouky, and senior VP Arthur J. Shannon will represent the company. A live webcast and audio archive will be available on Bausch Health’s Investor Relations page. The company focuses on improving lives through its healthcare products across eye health, gastroenterology, and dermatology sectors.

Positive
  • Participation in a major healthcare conference, enhancing visibility and potential investor engagement.
  • Presence of top executives at the event, signaling strong leadership commitment.
Negative
  • None.

LAVAL, QC, May 25, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that Joseph C. Papa, chairman and chief executive officer; Sam Eldessouky, senior vice president and corporate controller; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Jefferies Healthcare Conference on June 2, 2021 at 11:00 a.m. ET.

A live webcast and audio archive of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2021.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

Investor Contact:              

Media Contact:

Arthur Shannon                    

Lainie Keller

arthur.shannon@bauschhealth.com         

lainie.keller@bauschhealth.com

(514) 856-3855             

(908) 927-1198

(877) 281-6642 (toll free)  


 

Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-announces-participation-at-the-jefferies-healthcare-conference-301297956.html

SOURCE Bausch Health Companies Inc.

FAQ

When is Bausch Health participating in the Jefferies Healthcare Conference?

Bausch Health will participate in the Jefferies Healthcare Conference on June 2, 2021, at 11:00 a.m. ET.

Who will represent Bausch Health at the Jefferies Healthcare Conference?

CEO Joseph C. Papa, senior VP Sam Eldessouky, and senior VP Arthur J. Shannon will represent Bausch Health.

Where can I watch the Bausch Health presentation at the Jefferies Healthcare Conference?

The presentation will be available via a live webcast on Bausch Health’s Investor Relations page.

What does Bausch Health focus on in terms of healthcare products?

Bausch Health specializes in pharmaceuticals, medical devices, and over-the-counter products, primarily in eye health, gastroenterology, and dermatology.

Bausch Health Companies Inc.

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Stock Data

3.17B
367.80M
11.08%
77.48%
3.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
QUEBEC